Delivery Order SPE2DE24D0013-SPE2D626F451P
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $13,709.36 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, identified as XPRSMVP-10, carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic solutions. The...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,680 with an ultimate completion date of November 13, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, issued without a set-aside designation, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. As a manufacturer of advanced diagnostic systems and reagents, Cepheid supplies the federal...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $33,200.20 by the Defense Logistics Agency Medical Supply Chain on November 25, 2025, with an ultimate completion date of December 3, 2025. This delivery order, designated XPRSMVP-10, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. As a leading manufacturer of advanced molecular diagnostic systems and reagents, Cepheid supplies the Defense...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,259.80 by the Defense Logistics Agency Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued under contract number GXGBSLBXC-10, carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F451PDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,530.08 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work performed at Cepheid's Sunnyvale, CA facility. As a manufacturer of advanced molecular diagnostic systems and reagents, Cepheid delivers diagnostic solutions—primarily its GeneXpert platform and associated test kits—for detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other clinical conditions that support federal healthcare operations. This delivery order falls within the broader context of Cepheid's extensive federal contracting relationship with the Defense Logistics Agency Medical Supply Chain and other federal healthcare entities including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency. Cepheid maintains significant indefinite delivery contracts with the VA, including a $32.8 million single-award contract with VISN 6 extending through September 2030, which has generated numerous delivery orders for molecular diagnostic testing system reagents and assays. The company's consistent receipt of firm fixed-price contracts across multiple federal agencies demonstrates its established competitive positioning as a primary supplier of molecular diagnostic capabilities to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 11/23/25 |